?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika
Filter & Suche
496 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
496 Unternehmen gefunden • Seite 4 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Theravance Biopharma Inc | 69.0 | Arzneimittel (Pharmazeutisch) | USA | 0.9 Mrd. USD | 16.43 | 17.06 | 8.48 | 3.05 | ▲ 8.38% | - | - | - | - | 98.54% | ▼ -86.80% | -12.33% | ▲ 101.36% | 221.93% | ▲ 155.46% | 8 / 9 | 2,84 | 6-fach | 21 / 100 | −27,3 / 100 | −3,84 |
 | H Lundbeck A/S | 68.8 | Arzneimittel (Pharmazeutisch) | Dänemark | 8.0 Mrd. USD | 13.80 | 11.54 | 2.09 | 1.99 | ▲ 6.63% | ▲ 15.09% | 2.18% | - | 2 Jahre | 13.11% | ▲ 1.38% | 26.05% | ▲ 2.67% | 17.84% | ▲ 1.31% | 5 / 9 | 3,49 | 15-fach | 36 / 100 | −3,2 / 100 | −2,37 |
 | Otsuka Holdings Co Ltd ADR | 68.7 | Arzneimittel (Pharmazeutisch) | Japan | 40.3 Mrd. USD | 15.41 | 19.34 | 2.38 | 1.96 | ▲ 12.72% | ▲ 20.78% | 1.38% | ▼ -60.26% | - | 14.71% | ▲ 1.97% | 16.71% | ▲ 1.80% | 12.79% | ▲ 1.38% | 7 / 9 | 6,87 | 23-fach | 45 / 100 | −1,0 / 100 | −2,47 |
| Joincare Pharmaceutical Group Industry Co Ltd | 68.6 | Arzneimittel (Pharmazeutisch) | China | 2.7 Mrd. USD | 16.05 | - | 1.35 | 1.27 | ▲ 2.39% | ▲ 3.57% | 9.44% | ▲ 2.02% | - | 8.78% | ▲ 0.10% | 20.94% | ▲ 0.72% | 20.54% | ▲ 2.85% | 7 / 9 | 7,32 | 28-fach | 36 / 100 | −9,8 / 100 | −3,48 |
| Shandong Shanda Wit Science and Technology Co Ltd | 68.0 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | 13.25 | 22.53 | 2.93 | 2.13 | ▲ 4.12% | ▲ 12.97% | 10.45% | - | - | 24.01% | ▲ 1.22% | 53.55% | ▲ 3.21% | 54.89% | ▲ 4.13% | 8 / 9 | 14,97 | > 50-fach | 54 / 100 | −21,0 / 100 | −4,11 |
 | Alkermes Plc | 67.9 | Arzneimittel (Biotechnologie) | Irland | 7.6 Mrd. USD | 114.81 | 34.26 | 4.55 | 4.20 | ▲ 7.28% | - | - | - | - | 16.37% | ▲ 7.88% | 17.21% | ▲ 4.53% | 32.55% | ▲ 8.03% | 7 / 9 | 6,14 | 21-fach | 51 / 100 | −11,0 / 100 | −3,63 |
 | Rigel Pharmaceuticals Inc | 67.9 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | 2.92 | 11.83 | 3.39 | 2.21 | ▲ 22.06% | - | - | - | - | 124.72% | ▲ 33.19% | 42.63% | ▲ 16.17% | 25.71% | ▲ 12.34% | 7 / 9 | 0,36 | 6-fach | 53 / 100 | 56,7 / 100 | 1,58 |
 | Pharmaron Beijing Co Ltd | 67.8 | Arzneimittel (Biotechnologie) | China | 11.0 Mrd. USD | 41.47 | - | 4.58 | 4.35 | ▲ 22.39% | ▲ 7.25% | 0.54% | - | - | 11.80% | ▼ -1.98% | 15.78% | ▼ -1.92% | 3.92% | ▲ 2.10% | 8 / 9 | 2,73 | 10-fach | 19 / 100 | −5,9 / 100 | −2,93 |
 | Siegfried Holding Ltd | 67.8 | Arzneimittel (Pharmazeutisch) | Schweiz | 3.9 Mrd. USD | 18.45 | - | 2.36 | 3.18 | ▲ 9.46% | ▲ 22.61% | 0.55% | - | 10 Jahre | 12.70% | ▲ 0.77% | 15.84% | ▲ 0.50% | 0.75% | ▼ -0.28% | 6 / 9 | 5,20 | 22-fach | 16 / 100 | −2,5 / 100 | −2,44 |
 | Keros Therapeutics Inc | 67.7 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 6.94 | 0.88 | ▲ 149.98% | - | - | - | - | 35.65% | ▼ -409.83% | 28.94% | ▼ -474.62% | 43.41% | ▼ -351.40% | 6 / 9 | 12,03 | - | 72 / 100 | −6,1 / 100 | 4,29 |
 | Biomerieux SA | 67.7 | Arzneimittel (Biotechnologie) | Frankreich | 12.0 Mrd. USD | 23.20 | 18.33 | 2.69 | 2.50 | ▲ 5.47% | ▼ -0.34% | 1.09% | ▲ 9.59% | 1 Jahre | 9.77% | ▼ -1.78% | 13.79% | ▼ -1.87% | 11.13% | ▼ -0.58% | 6 / 9 | 5,56 | 44-fach | 38 / 100 | −7,0 / 100 | −2,74 |
 | Halozyme Therapeutics Inc | 67.4 | Arzneimittel (Biotechnologie) | USA | 14.8 Mrd. USD | 35.68 | 18.31 | 8.87 | 102.81 | ▲ 39.16% | ▲ 19.68% | - | - | - | 22.69% | ▼ -12.32% | 57.47% | ▲ 0.42% | 46.15% | ▼ -3.16% | 6 / 9 | 3,07 | 26-fach | 46 / 100 | −13,3 / 100 | −2,54 |
 | Sk Biopharmaceuticals Co Ltd | 67.3 | Arzneimittel (Biotechnologie) | Südkorea | 4.6 Mrd. USD | 15.23 | 28.18 | 7.09 | 5.98 | ▲ 93.58% | - | - | - | - | 37.77% | ▲ 14.52% | 28.86% | ▲ 8.32% | 20.77% | ▲ 16.98% | 6 / 9 | 4,37 | 8-fach | 56 / 100 | 7,6 / 100 | −1,67 |
 | Basilea Pharmaceutica AG | 67.3 | Arzneimittel (Biotechnologie) | Schweiz | 1.1 Mrd. USD | 17.39 | 16.47 | 3.68 | 5.61 | ▲ 12.73% | - | - | - | - | 17.31% | ▲ 7.28% | 22.20% | ▲ 5.96% | 25.49% | ▲ 12.77% | 7 / 9 | −3,45 | 7-fach | 68 / 100 | −7,8 / 100 | −2,85 |
| Hubei Jumpcan Pharmaceutical Co Ltd | 67.3 | Arzneimittel (Pharmazeutisch) | China | 3.7 Mrd. USD | 13.42 | - | 4.25 | 1.79 | ▲ 0.17% | ▲ 6.84% | 6.60% | - | 1 Jahre | 28.59% | ▲ 1.96% | 30.19% | ▲ 1.85% | 17.73% | ▼ -0.91% | 5 / 9 | 11,87 | > 50-fach | 28 / 100 | 3,3 / 100 | −3,21 |
| LAKEFRONT BIOTHERAPEUTICS NV | 67.2 | Arzneimittel (Biotechnologie) | Belgien | 2.1 Mrd. USD | 3.19 | - | 1.92 | 0.58 | ▲ 18.40% | - | - | - | - | 28.85% | ▲ 17.95% | 42.23% | ▲ 13.74% | -18.94% | ▲ 15.43% | 7 / 9 | 26,34 | > 50-fach | 30 / 100 | 15,2 / 100 | 0,13 |
 | BB Biotech AG | 67.0 | Arzneimittel (Biotechnologie) | Schweiz | 3.5 Mrd. USD | 2.63 | 11.86 | 12.92 | 0.87 | ▼ -35.71% | ▼ -3.51% | 4.48% | ▼ -8.97% | - | 752.66% | ▲ 126.71% | 763.99% | ▲ 129.79% | 402.47% | ▲ 77.16% | - | 423,26 | 41-fach | 3 / 100 | 9,7 / 100 | - |
 | Roche Holding AG | 66.8 | Arzneimittel (Pharmazeutisch) | Schweiz | 395.9 Mrd. USD | 26.33 | 22.01 | 5.33 | 9.94 | ▲ 1.07% | ▼ -2.06% | 2.42% | ▲ 1.49% | 29 Jahre | 20.94% | ▼ -0.88% | 26.59% | ▼ -0.91% | 22.89% | ▼ -0.87% | 6 / 9 | 4,22 | 12-fach | 46 / 100 | −5,1 / 100 | −2,76 |
 | Krystal Biotech Inc | 66.6 | Arzneimittel (Biotechnologie) | USA | 9.5 Mrd. USD | 39.40 | 36.91 | 21.60 | 7.00 | - | - | - | - | - | 52.64% | - | 41.45% | - | 48.55% | - | 6 / 9 | 16,76 | unbegrenzt | 27 / 100 | 0,3 / 100 | −2,26 |
| Innovent Biologics Inc | 66.6 | Arzneimittel (Biotechnologie) | China | 18.2 Mrd. USD | 99.69 | 9.31 | 7.77 | 5.84 | ▲ 27.68% | - | - | - | - | 6.24% | ▲ 20.63% | 5.63% | ▲ 21.18% | 71.45% | ▲ 39.23% | 7 / 9 | 2,45 | −0,6-fach | 27 / 100 | −25,1 / 100 | −3,45 |
| Tsumura & Co | 66.4 | Arzneimittel (Pharmazeutisch) | Japan | 2.3 Mrd. USD | 21.93 | - | 2.43 | 1.35 | ▲ 10.60% | ▲ 12.89% | 2.32% | ▲ 19.81% | 3 Jahre | 14.60% | ▲ 0.63% | 18.29% | ▲ 0.92% | -5.01% | ▼ -2.56% | 4 / 9 | 6,75 | > 50-fach | 17 / 100 | 0,6 / 100 | −1,97 |
| Hanmi Pharm Co Ltd | 66.3 | Arzneimittel (Pharmazeutisch) | Südkorea | 3.7 Mrd. USD | 22.71 | 27.04 | 2.98 | 3.51 | ▲ 7.54% | ▲ 69.95% | 0.54% | - | - | 10.96% | ▲ 1.27% | 16.66% | ▲ 1.51% | 6.24% | ▼ -1.89% | 8 / 9 | 4,98 | 9-fach | 45 / 100 | −0,2 / 100 | −2,08 |
| Mayinglong Pharmaceutical Group Co Ltd | 66.1 | Arzneimittel (Pharmazeutisch) | China | 1.6 Mrd. USD | 17.56 | 57.78 | 2.65 | 2.26 | ▲ 6.73% | ▲ 6.77% | 2.92% | ▲ 8.76% | 3 Jahre | 15.04% | ▲ 0.32% | 17.32% | ▲ 0.43% | 12.44% | ▼ -0.62% | 8 / 9 | 11,89 | > 50-fach | 36 / 100 | −0,4 / 100 | −3,33 |
 | AbbVie Inc | 65.9 | Arzneimittel (Biotechnologie) | USA | 505.4 Mrd. USD | 80.04 | 27.75 | 7.85 | -85.15 | ▲ 5.95% | ▼ -1.75% | 2.42% | ▲ 5.88% | 12 Jahre | 6.91% | ▼ -4.01% | 32.85% | ▼ -1.31% | 29.13% | ▼ -3.01% | 8 / 9 | −0,62 | 3-fach | 32 / 100 | −11,1 / 100 | −2,94 |
 | Biomarin Pharmaceutical Inc | 65.9 | Arzneimittel (Biotechnologie) | USA | 10.8 Mrd. USD | 148.55 | 14.79 | 3.18 | 1.71 | ▲ 11.60% | ▼ -16.49% | - | - | - | 10.83% | ▲ 3.68% | 16.56% | ▲ 5.13% | 22.51% | ▲ 3.90% | 6 / 9 | 7,50 | 31-fach | 33 / 100 | −6,3 / 100 | −2,67 |
